Skip to main content

We are working to raise awareness of antimicrobial resistance (AMR), and establish best practice in the regions where it’s needed most.

AMR is a growing global challenge, and it's too big to tackle alone. More than ever, we need a sector-wide approach, with government, society and pharmaceutical companies all playing their part. That’s why, at Centrient Pharmaceuticals, we’re working closely with our customers and partners, as well as key industry stakeholders to address this critical global issue. Our goal is to develop understanding and encourage others to join the fight against AMR.
Through the Sustainability Through Excellence in Manufacturing (STEM) programme, we are sharing our experience and insight with industry players the world over via a series of expert workshops. Supported by our partners, such as the Indian Institute of Technology, these efforts are helping to raise the bar and enable safe, responsible production of life-saving antibiotics.
A core goal of the workshops is to develop an understanding of the latest science on antibiotic manufacturing discharge, including the advanced technologies and processes now available for removing antibiotic residues from pharmaceutical waste. A key focal point is the Predicted No-Effect Concentration (PNEC): the level of concentration of an antibiotic in water at which there is unlikely to be any adverse environmental effect or risk of antimicrobial resistance developing. Developed by the AMR Industry Alliance, these science-driven, risk-based targets have been adopted by members of the Alliance around the world. 

By sharing our knowledge and working side-by-side with different industry players around the world, we hope to consign AMR to the history books for good!